Latest Breaking News On - Adult onset leukoencephalopathy - Page 1 : comparemela.com

Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting

WATERTOWN, Mass., March 13, 2024 Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,.

United statesDavids lynchMegan mcgrathZbigniew wszolekLeah gibsonAbbie renouxVigil neuroscience incInvestor relations corporate communicationsUniversity college london institute of neurologyAmerican academy of neurologyNational hospital for neurology neurosurgeryAnnual meetingInterim resultsFirst interventional phaseAdult onset leukoencephalopathyAxonal spheroids

Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024

Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

West palm beachUnited statesIvana magovLeah gibsonMegan mcgrathInvestor relations corporate communicationsExchange commissionVigil neuroscience incVigil neuroscienceChief executive officerClinical overlapAdult onset leukoencephalopathyAxonal spheroidsPigmented gliaMultiple sclerosisGenetic testing

Sittingbourne carer warns others about rare genetic disease after mum diagnosed with leukoencephalopathy

Sittingbourne carer warns others about rare genetic disease after mum diagnosed with leukoencephalopathy
kentonline.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kentonline.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesFiona willisCara simmondsPeter bealeTamsin kimberNational organization for rare disordersLeukodystrophy charityNational hospital for neurologyAdult onset leukoencephalopathyAxonal spheroidsPigmented gliaNational organizationRare disordersNational hospital

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesIvana magovMegan mcgrath macdougallAmerican academy of neurologyVigil neuroscience incAnnual meetingChief executive officerMultiple ascending intravenous dose studyHealthy volunteersGeneral neurologyProspective natural history studyAdult onset leukoencephalopathyAxonal spheroidsPigmented gliaFrontotemporal dementiaMultiple sclerosis

Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update

08.08.2022 - – Initiated a Phase 1 trial of VGL101 in healthy volunteers in Australia – – Received U.S. FDA orphan drug designation for VGL101 for the treatment of patients with ALSP – – Prioritizing VGL101 in ALSP and small molecule TREM2 agonist programs; .

United kingdomSuzanne bruhnIvana magovMegan mcgrath macdougallExchange commissionAgonist programAlzheimer association international conferenceEuropean academy of neurologyDrug administrationVigil neuroscience incChief executive officerMonoclonal antibodyDrug designationEuropean academyOnset leukoencephalopathyAxonal spheroids